BIOMAT Database Logo BIOMAT Database Logo

Lysine sulfonamides as novel HIV-protease inhibitors: optimization of the Nepsilon-acyl-phenyl spacer. 2003

Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Pharmacor Inc, 535 Cartier West, blvd, Laval, Quebec, Canada H7V 3S8. bstranix@procyonbiopharm.com

A series of Nalpha-isobutyl-Nalpha-arylsulfonamido-(Nepsilon acyl) lysine and lysinol derivatives were prepared and evaluated as inhibitors of HIV protease and wild type virus. A simple original synthesis was devised to form Nalpha-(arylsulfonamide)-Nalpha-isobutyl lysine, which could be easily acylated with carboxylic acids at the Nepsilon position. A two-atom spacer was found to be optimal between this acyl group and a phenyl yielding compounds of sub-nanomolar potency on purified enzyme.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV

Related Publications

Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-acyl aromatic alpha-amino acids.
July 2006, Bioorganic & medicinal chemistry letters,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Two sulfonamides-containing dihydropyrone derivatives as HIV protease inhibitors.
July 2001, Archiv der Pharmazie,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Optimization of pyrrolidinone based HIV protease inhibitors.
January 2005, Bioorganic & medicinal chemistry letters,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3.
January 2006, Bioorganic & medicinal chemistry,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication.
July 2013, Bioorganic & medicinal chemistry letters,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
The synthesis of novel HIV-protease inhibitors.
October 1994, Bioorganic & medicinal chemistry,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals.
June 2003, Bioorganic & medicinal chemistry,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides.
January 2012, Bioorganic & medicinal chemistry letters,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors.
March 1991, Journal of medicinal chemistry,
Brent R Stranix, and Gilles Sauvé, and Abderrahim Bouzide, and Alexandre Coté, and Guy Sévigny, and Jocelyn Yelle
Prenylisoflavonoids from Erythrina senegalensis as novel HIV-1 protease inhibitors.
February 2009, Planta medica,
Copied contents to your clipboard!